Search results
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Insmed stock target lifted on positive trial results By Investing.com
Investing.com· 6 days agoOn Wednesday, Wells Fargo maintained an Overweight rating on shares of Insmed (NASDAQ:INSM)...
Insmed Inc [INSM] stock for 1,165,725 USD was sold by Flammer Martina M.D. – Knox Daily
Knox Daily· 5 days agoUpon closing the transaction, the insider’s holdings decreased to 103,806 shares, worth approximately $6.05 million. As published in their initiating research note from Truist on April 23, 2024 ...
Insmed (NASDAQ:INSM) Price Target Raised to $67.00
ETF DAILY NEWS· 5 days agoInsmed (NASDAQ:INSM – Get Free Report) had its price objective boosted by equities researchers at TD Cowen from $45.00 to $67.00 in a research report issued to clients and ...
Unpacking the Latest Options Trading Trends in Insmed - Insmed (NASDAQ:INSM)
Benzinga· 5 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Insmed . Looking at options history for Insmed INSM we detected 13 trades ...
Sara Bonstein Sells 220,564 Shares of Insmed Incorporated (NASDAQ:INSM) Stock
ETF DAILY NEWS· 3 days agoInsmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 220,564 shares of Insmed stock in a transaction dated Wednesday, May 29th. Following the transaction ...
Insmed (NASDAQ:INSM) Rating Reiterated by Bank of America
ETF DAILY NEWS· 6 days agoInsmed (NASDAQ:INSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Bank of America in a research note issued on Tuesday, Benzinga reports. Bank ...
Behind the Scenes of Insmed's Latest Options Trends - Insmed (NASDAQ:INSM)
Benzinga· 6 days agoLoading... Loading... Financial giants have made a conspicuous bearish move on Insmed. Our analysis of options history for Insmed INSM revealed 48 unusual trades. Delving ...
Wolfe Research lifts Insmed stock PT by $12 on strong drug prospects By Investing.com
Investing.com· 7 days agoOn Wednesday, Wolfe Research increased its price target on shares of Insmed (NASDAQ:INSM)...
Insmed shares target raised by H.C. Wainwright on positive trial data By Investing.com
Investing.com· 7 days agoWednesday, H.C. Wainwright increased the price target for Insmed (NASDAQ:INSM) shares to $70 from...